Read + Share
Amedeo Smart
Independent Medical Education
Feld JJ, Forns X, Dylla DE, Kumada H, et al. Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts. J Viral Hepat 2022;29:1050-1061.PMID: 36036117
Email
LinkedIn
Facebook
Twitter
Privacy Policy